Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
T. Takagi, E. Gabazza, A. Fujiwara, H. Nakahara, H. Fujimoto, A. Yamaguchi, H. Yasui, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, Y. Takei, O. Taguchi (Tsu/Mie, Japan). Procoagulant and anticoagulant factors in patients with sleep apnea. Eur Respir J 2008; 32: Suppl. 52, 3231

Member's Comments

No comment yet.

Related content which might interest you: Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea Source: Eur Respir J 2012; 39: 913-918 Year: 2012 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006 Sleep apnoea as a risk factor for stroke Source: 5th Sleep and Breathing Conference Year: 2019 Impact of antihypertensive drugs on Watch-PAT variables in patients with obstructive sleep apnea. Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019 Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Source: Eur Respir J 2009; 33: 574-580 Year: 2009 Serum fibrinogen in patients with obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Circadian rythm of circulating microparticles in patients with obstructive sleep apnea Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Menopause and cardiovascular risk factors in sleep apnea Source: Eur Respir J 2006; 28: Suppl. 50, 200s Year: 2006 Prevalence of complex sleep apnea among German patients with obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Sleep apnea as a cause of sleep misperception in elderly insomnia patients Source: International Congress 2017 – Phenotyping obstructive sleep apnoea Year: 2017 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019 Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021